stoxline Quote Chart Rank Option Currency Glossary
  
Check-Cap Ltd. (CHEK)
2.19  -0.04 (-1.79%)    06-18 09:31
Open: 2.19
High: 2.19
Volume: 427
  
Pre. Close: 2.23
Low: 2.19
Market Cap: 13(M)
Technical analysis
2024-06-18 10:48:33 AM
Short term     
Mid term     
Targets 6-month :  2.68 1-year :  3.13
Resists First :  2.29 Second :  2.68
Pivot price 2.24
Supports First :  2.14 Second :  2.05
MAs MA(5) :  2.19 MA(20) :  2.24
MA(100) :  2.22 MA(250) :  2.71
MACD MACD :  -0.1 Signal :  -0.1
%K %D K(14,3) :  59 D(3) :  46.4
RSI RSI(14): 45.3
52-week High :  4.62 Low :  1.77
Price, MAs and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.
[ CHEK ] has closed above bottom band by 20.1%. Bollinger Bands are 59.7% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 34 bars. This is a sign that the market may be about to initiate a new trend.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 2.25 - 2.26 2.26 - 2.27
Low: 2.09 - 2.1 2.1 - 2.11
Close: 2.22 - 2.24 2.24 - 2.26
Company Description

Check-Cap Ltd., a clinical stage medical diagnostics company, engages in the development of a capsule-based screening technology that utilizes ultra-low-dose X-rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities in Israel. Its C-Scan system consists of C-Scan Cap, an X-ray scanning capsule for detection of suspected polyps; C-Scan Track, a disposable system attached to the patient's back through biocompatible adhesive skin patches; and C-Scan View software, a client/server-based application that enables procedure data download from the C-Scan Track, data analysis, and report generation. The company was incorporated in 2004 and is based in Isfiya, Israel.

Headline News

Tue, 18 Jun 2024
Check-Cap (NASDAQ:CHEK) Now Covered by StockNews.com - Defense World

Tue, 18 Jun 2024
Check-Cap (NASDAQ:CHEK) Share Price Crosses Below Fifty Day Moving Average of $2.25 - Defense World

Mon, 15 Apr 2024
Check-Cap Ltd. Calls for Shareholder Vote - TipRanks.com - TipRanks

Mon, 08 Apr 2024
Check-Cap Ltd. Approaches Key Merger Vote - TipRanks.com - TipRanks

Tue, 26 Mar 2024
AI-Powered Real Estate Marketplace Nobul AI To Acquire Medical-Diagnostics Company Check-Cap - MSN

Tue, 26 Mar 2024
Check-Cap jumps on Nobul AI business combination (NASDAQ:CHEK) - Seeking Alpha

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Underperform
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Outperform
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Outperform
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Underperform
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Underperform
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Underperform
Stock Basics & Statistics
Exchange:
NASDAQ
Sector:
Healthcare
Industry:
Medical - Diagnostics & Research
Shares Out 6 (M)
Shares Float 4 (M)
Held by Insiders 25.1 (%)
Held by Institutions 0.1 (%)
Shares Short 206 (K)
Shares Short P.Month 131 (K)
Stock Financials
EPS -3
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 4.05
Profit Margin 0 %
Operating Margin 0 %
Return on Assets (ttm) -31.7 %
Return on Equity (ttm) -54.1 %
Qtrly Rev. Growth 0 %
Gross Profit (p.s.) 0
Sales Per Share 0
EBITDA (p.s.) -3.02
Qtrly Earnings Growth 0 %
Operating Cash Flow -17 (M)
Levered Free Cash Flow -12 (M)
Stock Valuations
PE Ratio -0.74
PEG Ratio 0
Price to Book value 0.54
Price to Sales 0
Price to Cash Flow -0.76
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android